Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
Apple
AAPL
5
Gorilla Technology
GRRR
US Stock MarketDetailed Quotes
CYCN Cyclerion Therapeutics
- 2.5650
- -0.0650-2.47%
Close Mar 11 16:00 ET
- 2.5650
- 0.00000.00%
Post 16:00 ET
6.95MMarket Cap-2.12P/E (TTM)
2.6900High2.5311Low28.13KVolume2.6300Open2.6300Pre Close72.79KTurnover1.44%Turnover RatioLossP/E (Static)2.71MShares9.469952wk High0.79P/B5.01MFloat Cap1.270052wk Low--Dividend TTM1.95MShs Float420.0000Historical High--Div YieldTTM6.04%Amplitude1.2700Historical Low2.5870Avg Price1Lot Size
Cyclerion Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -57.31%3.23M | -57.31%3.23M | -68.47%2.87M | -18.67%4.59M | -20.55%5.7M | -43.42%7.57M | -43.42%7.57M | -55.36%9.11M | -81.40%5.64M | -82.57%7.17M |
| -Cash and cash equivalents | -57.31%3.23M | -57.31%3.23M | -68.47%2.87M | -18.67%4.59M | -20.55%5.7M | -43.42%7.57M | -43.42%7.57M | -55.36%9.11M | -81.40%5.64M | -82.57%7.17M |
| Receivables | --556K | --556K | --44K | ---- | ---- | --0 | --0 | --0 | --0 | -57.71%96K |
| -Accounts receivable | --556K | --556K | --44K | ---- | ---- | --0 | --0 | --0 | --0 | -57.71%96K |
| Prepaid assets | -4.75%421K | -4.75%421K | -14.46%621K | -88.89%116K | -45.68%308K | -45.09%442K | -45.09%442K | 35.45%726K | 61.36%1.04M | -43.69%567K |
| Other current assets | 45.45%16K | 45.45%16K | -63.33%11K | -97.43%11K | -98.01%10K | -97.95%11K | -97.95%11K | -93.85%30K | -11.20%428K | 5.45%503K |
| Total current assets | -47.35%4.23M | -47.35%4.23M | -64.03%3.55M | -33.71%4.72M | -27.85%6.01M | -45.86%8.02M | -45.86%8.02M | -54.45%9.86M | -77.55%7.11M | -80.54%8.34M |
| Non current assets | ||||||||||
| Net PPE | --0 | --0 | ---- | ---- | --0 | --0 | --0 | --0 | -14.12%1.13M | -14.71%1.17M |
| -Gross PPE | 0.00%126K | 0.00%126K | ---- | ---- | -89.24%126K | -96.29%126K | -96.29%126K | --0 | -7.89%3.29M | -67.66%1.17M |
| -Accumulated depreciation | 0.00%-126K | 0.00%-126K | ---- | ---- | ---126K | 94.22%-126K | 94.22%-126K | ---- | 4.28%-2.17M | ---- |
| Investments and advances | 0.00%5.35M | 0.00%5.35M | 0.00%5.35M | --5.35M | --5.35M | --5.35M | --5.35M | --5.35M | ---- | ---- |
| Other non current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -16.41%1.86M | -15.80%1.95M |
| Total non current assets | 0.00%5.35M | 0.00%5.35M | 0.00%5.35M | 79.29%5.35M | 71.42%5.35M | 64.16%5.35M | 64.16%5.35M | 57.49%5.35M | -15.56%2.98M | -15.40%3.12M |
| Total assets | -28.41%9.58M | -28.41%9.58M | -41.51%8.9M | -0.32%10.07M | -0.80%11.36M | -26.02%13.37M | -26.02%13.37M | -39.27%15.21M | -71.33%10.1M | -75.38%11.46M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -67.45%390K | -67.45%390K | -62.65%304K | -65.08%651K | -81.12%741K | -59.66%1.2M | -59.66%1.2M | -50.52%814K | -32.63%1.86M | 55.82%3.93M |
| -accounts payable | -67.45%390K | -67.45%390K | -62.65%304K | -65.08%651K | -81.12%741K | -59.66%1.2M | -59.66%1.2M | -50.52%814K | -32.63%1.86M | 55.82%3.93M |
| Current accrued expenses | -64.90%272K | -64.90%272K | -66.44%353K | -82.02%427K | -80.59%539K | -76.91%775K | -76.91%775K | -80.44%1.05M | -57.79%2.38M | -51.31%2.78M |
| Other current liabilities | -44.25%63K | -44.25%63K | -72.78%43K | 16.57%204K | 15.00%161K | 66.18%113K | 66.18%113K | -0.63%158K | -10.26%175K | -63.73%140K |
| Current liabilities | -65.24%725K | -65.24%725K | -70.10%700K | -74.09%1.28M | -80.87%1.44M | -72.65%2.09M | -72.65%2.09M | -72.55%2.34M | -49.79%4.95M | -20.65%7.53M |
| Non current liabilities | ||||||||||
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total liabilities | -65.24%725K | -65.24%725K | -70.10%700K | -74.09%1.28M | -80.87%1.44M | -72.65%2.09M | -72.65%2.09M | -72.55%2.34M | -49.79%4.95M | -20.65%7.53M |
| Shareholders'equity | ||||||||||
| Share capital | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -common stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | ---- |
| Retained earnings | -1.16%-267.49M | -1.16%-267.49M | -2.02%-268.02M | 1.11%-267.3M | 0.06%-265.96M | -2.03%-264.42M | -2.03%-264.42M | -4.28%-262.72M | -11.95%-270.29M | -16.69%-266.11M |
| Paid-in capital | 0.23%276.34M | 0.23%276.34M | 0.22%276.22M | 0.23%276.08M | 2.16%275.9M | 2.26%275.72M | 2.26%275.72M | 2.65%275.61M | 3.23%275.46M | 1.86%270.05M |
| Gains losses not affecting retained earnings | --0 | --0 | --0 | --0 | 15.79%-16K | 40.00%-12K | 40.00%-12K | 35.71%-18K | 36.00%-16K | 20.83%-19K |
| Total stockholders'equity | -21.60%8.85M | -21.60%8.85M | -36.32%8.2M | 70.54%8.78M | 152.82%9.92M | 8.00%11.29M | 8.00%11.29M | -22.10%12.87M | -79.69%5.15M | -89.40%3.93M |
| Total equity | -21.60%8.85M | -21.60%8.85M | -36.32%8.2M | 70.54%8.78M | 152.82%9.92M | 8.00%11.29M | 8.00%11.29M | -22.10%12.87M | -79.69%5.15M | -89.40%3.93M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |